Search Results for: CFTR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
RNF5 ring finger protein 5
  • ABC-family proteins mediated transport
  • Defective CFTR causes cystic fibrosis
  • ER Quality Control Compartment (ERQC)
SLC4A7 solute carrier family 4 member 7
  • Bicarbonate transporters
SLC4A8 solute carrier family 4 member 8
  • Bicarbonate transporters
SLC9A3R1 SLC9A3 regulator 1
  • Nephrolithiasis/osteoporosis, hypophosphatemic
SLC9A3R2 SLC9A3 regulator 2
SLC9A6 solute carrier family 9 member A6
  • Sodium/Proton exchangers
  • Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
SNAP23 synaptosome associated protein 23
  • ER-Phagosome pathway
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • trans-Golgi Network Vesicle Budding
  • Neutrophil degranulation
STUB1 STIP1 homology and U-box containing protein 1
  • Downregulation of TGF-beta receptor signaling
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
  • Downregulation of ERBB2 signaling
  • Regulation of RUNX2 expression and activity
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
STX1A syntaxin 1A
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Insulin processing
  • Regulation of insulin secretion
  • Other interleukin signaling
  • Toxicity of botulinum toxin type C (botC)
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • GABA synthesis, release, reuptake and degradation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
UBE2I ubiquitin conjugating enzyme E2 I
  • Meiotic synapsis
  • Vitamin D (calciferol) metabolism
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMOylation of DNA damage response and repair proteins
  • SUMO E3 ligases SUMOylate target proteins
  • SUMOylation of transcription factors
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Processing of DNA double-strand break ends
  • Formation of Incision Complex in GG-NER
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Postmitotic nuclear pore complex (NPC) reformation
  • Maturation of nucleoprotein
  • Maturation of nucleoprotein

Page 2 out of 2 pages